Below are the most recent publications written about "Thrombin" by people in Profiles.
-
Wurtzel JGT, Lazar S, Askari S, Zhao X, Severa J, Ayombil F, Michael JV, Camire RM, McKenzie SE, Stalker TJ, Ma P, Goldfinger LE. Plasma growth factors maintain constitutive translation in platelets to regulate reactivity and thrombotic potential. Blood Adv. 2024 03 26; 8(6):1550-1566.
-
Marar TT, Matzko CN, Wu J, Esmon CT, Sinno T, Brass LF, Stalker TJ, Tomaiuolo M. Thrombin spatial distribution determines protein C?activation during hemostasis and thrombosis. Blood. 2022 03 24; 139(12):1892-1902.
-
Renna SA, Michael JV, Kong X, Ma L, Ma P, Nieman MT, Edelstein LC, McKenzie SE. Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice. J Thromb Haemost. 2022 05; 20(5):1236-1247.
-
Marar TT, Martinez ND, Maroney SA, Siebert AE, Wu J, Stalker TJ, Tomaiuolo M, Delacroix S, Simari RD, Mast AE, Brass LF. The contribution of TFPIa to the hemostatic response to injury in mice. J Thromb Haemost. 2021 09; 19(9):2182-2192.
-
Abraham S, Ma L, Kong X, Askari S, Edelstein LC, McKenzie SE. PCTP contributes to human platelet activation by enhancing dense granule secretion. Thromb Res. 2021 06; 202:67-73.
-
B?hm M, Brueckmann M, Eikelboom JW, Ezekowitz M, Fr??dorf M, Hijazi Z, Hohnloser SH, Mahfoud F, Schmieder RE, Schumacher H, Wallentin L, Yusuf S. Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial. Eur Heart J. 2020 08 07; 41(30):2848-2859.
-
Bergstrom CP, Zia A, Sarode R, Nagalla S. Thrombin Generation in a patient with Triple Positive Antiphospholipid Syndrome Treated with Three Different Anticoagulants. Transfus Apher Sci. 2020 Oct; 59(5):102815.
-
Simonneau C, Yang J, Kong X, Kilker R, Edelstein L, Fortina P, Londin E, Horowitz A. Validation of a Miniaturized Permeability Assay Compatible with CRISPR-Mediated Genome-Wide Screen. Sci Rep. 2019 Oct 02; 9(1):14238.
-
Whitley MJ, Henke DM, Ghazi A, Nieman M, Stoller M, Simon LM, Chen E, Vesci J, Holinstat M, McKenzie SE, Shaw CA, Edelstein LC, Bray PF. The protease-activated receptor?4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor?4 desensitization, and is blocked by non-competitive P2Y12 inhibition. J Thromb Haemost. 2018 12; 16(12):2501-2514.
-
Mirramezani M, Herbig BA, Stalker TJ, Nettey L, Cooper M, Weisel JW, Diamond SL, Sinno T, Brass LF, Shadden SC, Tomaiuolo M. Platelet packing density is an independent regulator of the hemostatic response to injury. J Thromb Haemost. 2018 05; 16(5):973-983.